Today's Information |
Provided by: SCI Pharmtech, Inc. | |||||
SEQ_NO | 2 | Date of announcement | 2022/06/21 | Time of announcement | 15:08:39 |
Subject | List of the Company's elected directors. | ||||
Date of events | 2022/06/21 | To which item it meets | paragraph 6 | ||
Statement | 1.Date of occurrence of the change:2022/06/21 2.Elected or changed position (Please enter institutional director, institutional supervisor, independent director, natural-person director or natural-person supervisor): juristic-person director, independent director, natural-person director 3.Title and name of the previous position holder: (1)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Weichyun Wong (2)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Henry Chen (3)Director: Mercuries & Associates, Holding Ltd. Representative : Ms. Aurora Chen (4)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Wen-Chih Chou (5)Independent director: Mr. Ted Tu (6)Independent director: Mr. Hung-Chih Wu (7)Independent director: Mr. Chia-Chun Jay Chen 4.Resume of the previous position holder: (1)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Weichyun Wong General manager of SCI Pharmtech, Inc. (2)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Henry Chen Chairman of Mercuries & Associates, Ltd. (3)Director: Mercuries & Associates, Holding Ltd. Representative : Ms. Aurora Chen Director of Shanghai American School (4)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Wen-Chih Chou R&D manager of SCI Pharmtech, Inc. (5)Independent director: Mr. Ted Tu Chairman of Hsuan Ho technology Ltd. (6)Independent director: Mr. Hung-Chih Wu General manager of CHENG FONG CHEMICAL CO., LTD. (7)Independent director: Mr. Chia-Chun Jay Chen Professor of Department of Chemistry, National Taiwan Normal University. 5.Title and name of the new position holder: (1)Director: Mr. Weichyun Wong (2)Director: Mr. Henry Chen (3)Director: Mercuries & Associates, Holding Ltd. Representative : Ms. Aurora Chen (4)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Wen-Chih Chou (5)Independent director: Mr. Ted Tu (6)Independent director: Mr. Chia-Chun Jay Chen (7)Independent director: Mr. Vincent Wang 6.Resume of the new position holder: (1)Director: Mr. Weichyun Wong General manager of SCI Pharmtech, Inc. (2)Director: Mr. Henry Chen Chairman of Mercuries & Associates, Ltd. (3)Director: Mercuries & Associates, Holding Ltd. Representative : Ms. Aurora Chen Director of Yushan Pharmaceuticals Inc. (4)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Wen-Chih Chou Factory manager of SCI Pharmtech, Inc. (5)Independent director: Mr. Ted Tu Chairman of PharmaEngine, Inc. (6)Independent director: Mr. Chia-Chun Jay Chen Professor of Department of Chemistry, National Taiwan Normal University. (7)Independent director: Mr. Vincent Wang Chairman of SUNSINO DEVELOPMENT ASSOCIATE INC. 7.Circumstances of change (Please enter "resignation", "dismissal", "term expired", "death" or "new appointment"):tenure expired 8.Reason for the change:re-election due to tenure expiration 9.Number of shares held by the new position holder when elected: (1)Director: Mr. Weichyun Wong; 526,970 shares (2)Director: Mr. Henry Chen; 0 shares (3)Director: Mercuries & Associates, Holding Ltd. Representative : Ms. Aurora Chen; 30,283,358 shares (4)Director: Mercuries & Associates, Holding Ltd. Representative : Mr. Wen-Chih Chou; 30,283,358 shares (5)Independent director: Mr. Ted Tu; 0 share (6)Independent director: Mr. Chia-Chun Jay Chen; 0 share (7)Independent director: Mr. Vincent Wang; 6,000 shares 10.Original term (from __________ to __________):2019/06/21~2022/06/20 11.Effective date of the new appointment:2022/06/21 12.Turnover rate of directors of the same term:NA 13.Turnover rate of independent directors of the same term:NA 14.Turnover rate of supervisors of the same term:NA 15.Change in one-third or more of directors (Please enter "Yes" or "No"):No 16.Any other matters that need to be specified:NA |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
SCI Pharmtech Inc. published this content on 21 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 June 2022 07:23:02 UTC.